SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-097218
Filing Date
2020-08-20
Accepted
2020-08-20 16:04:51
Documents
7

Document Format Files

Seq Description Document Type Size
1 tm2028947-1_s3.htm S-3 220216
2 EXHIBIT 5.1 tm2028947d2_ex5-1.htm EX-5.1 11153
3 EXHIBIT 23.1 tm2028947d2_ex23-1.htm EX-23.1 3885
4 GRAPHIC tm2028947d2_ex5-1img01.jpg GRAPHIC 2904
5 GRAPHIC lg_milestonepharma-4c.jpg GRAPHIC 493784
6 GRAPHIC tm2028947d2_ex23-1img01.jpg GRAPHIC 2649
7 GRAPHIC tm2028947d2_ex23-1img02.jpg GRAPHIC 4954
  Complete submission text file 0001104659-20-097218.txt   892913
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-248198 | Film No.: 201120079
SIC: 2834 Pharmaceutical Preparations